Stay updated on Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    No significant modifications to the study details page were observed; differences appear limited to layout or presentation elements. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T12:48:14.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    37 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice with operating status guidance and a link to cc.nih.gov and opm.gov. - Updated version from v3.1.0 to v3.2.0.
    Difference
    4%
    Check dated 2025-10-05T17:38:11.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Upgrade from v3.0.2 to v3.1.0: version metadata updated; no substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T10:55:19.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2, indicating a page update. The 'Back to Top' navigation element has been removed.
    Difference
    0.2%
    Check dated 2025-09-14T00:42:42.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.2%
    Check dated 2025-09-06T21:34:46.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as new content related to various chemical compounds and diseases. Notably, previous references to specific genetic diseases and various antineoplastic agents have been removed.
    Difference
    4%
    Check dated 2025-08-30T15:59:52.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial page.